Delek US (DK) CEO gains 95,249 RSU shares, withholds 31,631 for taxes

Rhea-AI Filing Summary

Delek US Holdings President & CEO Avigal Soreq reported multiple equity award transactions in common stock. On March 9 and 10, 2026, he acquired 95,249 shares through grants and vesting of restricted stock units, including performance-based awards and a new grant that vests over three years.

Across the same dates, 31,631 shares were disposed of at prices of $40.13 and $40.64 per share to cover tax obligations upon vesting of equity awards. After these transactions, Soreq directly holds 315,296 shares of Delek US Holdings common stock, indicating these are routine compensation-related grants and tax withholdings rather than open-market trades.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Soreq Avigal

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		A(1)		15,015	A	$0	266,693	D
Common Stock	03/09/2026		F(2)		5,909	D	$40.13	260,784	D
Common Stock	03/10/2026		A(1)		52,552	A	$0	313,336	D
Common Stock	03/10/2026		A(3)		27,682	A	$0	341,018	D
Common Stock	03/10/2026		F(2)		25,722	D	$40.64	315,296	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares delivered upon the vesting of performance based restricted stock units.

2. Represents shares withheld for tax purposes upon vesting of equity awards.

3. Represents a grant of time-vesting restricted stock units that vest over three years.

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Delek US (DK) CEO Avigal Soreq report?

Avigal Soreq reported equity-related transactions involving Delek US common stock. He received restricted stock units through grants and vesting events, and some shares were delivered upon vesting of performance-based awards, with a portion withheld to satisfy tax obligations tied to these equity awards.

How many Delek US (DK) shares did the CEO acquire in these Form 4 filings?

The CEO acquired 95,249 shares of Delek US common stock through grant and vesting transactions. These shares were received at a stated price of $0.00 per share, reflecting equity compensation in the form of restricted stock units rather than open-market purchases of the company’s stock.

Why were some Delek US (DK) shares disposed of in Avigal Soreq’s Form 4?

31,631 shares were disposed of solely to cover tax obligations related to equity awards. The filing notes these dispositions represent shares withheld for tax purposes upon vesting, at prices of $40.13 and $40.64 per share, not discretionary stock sales for portfolio changes.

What ongoing vesting schedule applies to the new Delek US (DK) stock grant?

One transaction represents a grant of time-vesting restricted stock units that vest over three years. This means the CEO’s newly granted units will convert into common shares gradually during that three-year period, aligning compensation with continued service and long-term company performance.

How many Delek US (DK) shares does the CEO hold after these transactions?

Following the reported equity award grants, vesting events, and tax-related share withholdings, Avigal Soreq directly holds 315,296 shares of Delek US common stock. This post-transaction balance reflects his ongoing equity stake after all Form 4 transactions on March 9 and 10, 2026.

Do these Delek US (DK) Form 4 transactions indicate open-market buying or selling?

No open-market buying or selling is reported in this Form 4. The transactions consist of equity compensation grants, performance-based restricted stock vesting, and share dispositions classified as tax-withholding events, rather than discretionary purchases or sales on the open market.